September 12, 2011
The results of the global PIII ARISTOTLE trial, which evaluated the efficacy and safety of the oral direct Factor Xa inhibitor apixaban in comparison with warfarin in patients with atrial fibrillation presenting high risks for stroke, were reported at the...read more